|
|
SAN FRANCISCO (MedPage Today) -- Discontinuation of anticoagulation therapy based on patient-reported symptoms may not be as clear cut as is believed, according to high asymptomatic event rates found in an objective monitoring trial.
Read from Source
|
| |
| |
| | 66 |
| |
|
|
|
|
|
|
